Harbin Medisan Pharmaceutical Co., Ltd. (SHE:002900)

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Large Infusion	339.75M
Large Infusion Growth	-4.66%
Freeze-dried Powder Injection	227.94M
Freeze-dried Powder Injection Growth	-23.41%
Small Volume Injection	200.34M
Small Volume Injection Growth	13.82%
Solid Preparation	143.57M
Solid Preparation Growth	-37.41%
Veterinary Drugs	75.20M
Veterinary Drugs Growth	740.79%
Other Business	61.64M
Other Business Growth	80.82%
Import and Export Trade	58.17M
Import and Export Trade Growth	-26.10%
Raw Materials	8.84M
Raw Materials Growth	86.70%
Outsourcing Pharmaceutical Intermediates	7.66M
Other	9.36M
Other Growth	2023.06%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
China	1.07B
China Growth	-3.05%
Overseas	58.17M
Overseas Growth	-26.10%